KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $74.5 million.

  • Exact Sciences' Free Cash Flow rose 68.82% to $190.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.1 million, marking a year-over-year increase of 151.03%. This contributed to the annual value of $74.5 million for FY2024, which is 133.48% up from last year.
  • Exact Sciences' Free Cash Flow amounted to $74.5 million in FY2024, which was up 133.48% from $31.9 million recorded in FY2023.
  • Exact Sciences' 5-year Free Cash Flow high stood at $74.5 million for FY2024, and its period low was -$438.0 million during FY2022.
  • Moreover, its 3-year median value for Free Cash Flow was $31.9 million (2023), whereas its average is -$110.5 million.
  • In the last 5 years, Exact Sciences' Free Cash Flow plummeted by 84.04% in 2022 and then surged by 133.48% in 2024.
  • Exact Sciences' Free Cash Flow (Yearly) stood at -$274.9 million in 2020, then increased by 13.43% to -$238.0 million in 2021, then crashed by 84.04% to -$438.0 million in 2022, then skyrocketed by 107.29% to $31.9 million in 2023, then spiked by 133.48% to $74.5 million in 2024.